Fund manager · DSP

Chirag Dagli

Fund Manager- Equity at DSP. Runs 2 schemes worth ₹6,628 Cr.

Fund house
DSPThey run their schemes at DSP.
AUM they run
₹6,628 CrThe AUM of the schemes they run, as main or co-manager, at the latest month's end, as AMFI reports it. A scheme two people run counts for both.
Schemes
2 now · 0 beforeSchemes they run now, as main or co-manager, and ones they ran before, since Aug 2024.
Experience
22 yearsOver 22 Years of Experience

What Chirag Dagli's schemes hold^{(Dec 2020 – Sept 2026)}

What Chirag Dagli's schemes hold in Sept 2026. Tick up to 2 to plot them.
Plot	75 companies ·	₹ Cr
	IPCA Laboratories Limited	353
	Cipla	348
	Gland Pharma Limited	295
	Sai Life Sciences Limited	289
	Sun Pharmaceutical Ind Ltd	279
	Alkem Laboratories Limited	272
	Apollo Hospitals Enterprise Limited	263
	Globus Medical Inc	193
	HDFC Bank	184
	Cohance Lifesciences Limited	173
	Divi s Laboratories Limited	156
	ICICI Bank	155
	Alembic Pharmaceuticals Limited	130
	Axis Bank	109
	ICICI Lombard General Insurance Co	108
	Kovai Medical Center and Hospital Limited	106
	Indoco Remedies	105
	Pfizer	102
	Max Financial Services Limited	102
	Concord Biotech Limited	101
	Procter Gamble Health Limited	88.6
	Vijaya Diagnostic Centre Limited	88.5
	Syngene International Limited	85.8
	Info Edge India Limited	85.1
	Coforge Limited	82.8
	Kirloskar Oil Engines Limited	81.6
	Mahindra and Mahindra Limited	79.5
	Hero MotoCorp	75.3
	Intuitive Surgical	73.3
	Thyrocare Technologies Ltd	71.6
	APL Apollo Tubes	70.1
	Manipal Health Enterprises Ltd	69.4
	Unichem Laboratories	61.6
	Physicswallah Ltd	60.2
	Coal India	57.6
	ICICI Prudential Life Insurance Co Ltd	56.3
	KEI Industries Limited	55.6
	HDFC Asset Management Co Ltd	53.4
	UTI Asset Management Co Limited	50.5
	Bharat Petroleum Corp Ltd	47.3
	SCHAEFFLER I LTD	47.1
	Sudarshan Chemical Industries Limited	44.7
	Cyient Limited	42.2
	Nephrocare Health Services Ltd	41.9
	Tube Investments of India Ltd	41.5
	Polycab India Limited	41
	Archean Chemical Industries Limited	40.4
	Indigo Paints Limited	38
	Hindustan Aeronautics Limited	37.7
	Aarti Drugs Limited	36.7

IPCA Laboratories Limited
Cipla

Market value of each ticked company across the schemes Chirag Dagli runs, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	IPCA Laboratories Limited	Cipla
Sept 2025	₹253 Cr	₹341 Cr
Oct 2025	₹240 Cr	₹340 Cr
Nov 2025	₹274 Cr	₹347 Cr
Dec 2025	₹268 Cr	₹343 Cr
Jan 2026	₹278 Cr	₹303 Cr
Feb 2026	₹289 Cr	₹309 Cr
Mar 2026	₹302 Cr	₹280 Cr
Apr 2026	₹298 Cr	₹300 Cr
May 2026	₹297 Cr	₹321 Cr
Jun 2026	₹331 Cr	₹363 Cr
Jul 2026	₹340 Cr	₹381 Cr
Aug 2026	₹384 Cr	₹364 Cr
Sept 2026	₹353 Cr	₹348 Cr

Fig. 1.Market value of each ticked company across the schemes Chirag Dagli runs, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of AUM
Large Cap	16	28.67

Mid Cap	14	20.93

Small Cap	40	38.50

Foreign	4	4.65

Unlisted	1	1.05

Cash & others		6.21

Sectors

Companies

Fig. 2.What the schemes this manager runs hold, all together, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

What Chirag Dagli bought and sold^{(Oct 2025 – Sept 2026)}

What Chirag Dagli bought and sold. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.